These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18627530)

  • 1. Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage.
    Yokoyama S; Feige E; Poling LL; Levy C; Widlund HR; Khaled M; Kung AL; Fisher DE
    Pigment Cell Melanoma Res; 2008 Aug; 21(4):457-63. PubMed ID: 18627530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
    Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
    Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for ATF2 in regulating MITF and melanoma development.
    Shah M; Bhoumik A; Goel V; Dewing A; Breitwieser W; Kluger H; Krajewski S; Krajewska M; Dehart J; Lau E; Kallenberg DM; Jeong H; Eroshkin A; Bennett DC; Chin L; Bosenberg M; Jones N; Ronai ZA
    PLoS Genet; 2010 Dec; 6(12):e1001258. PubMed ID: 21203491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MITF: master regulator of melanocyte development and melanoma oncogene.
    Levy C; Khaled M; Fisher DE
    Trends Mol Med; 2006 Sep; 12(9):406-14. PubMed ID: 16899407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.
    Davis IJ; Kim JJ; Ozsolak F; Widlund HR; Rozenblatt-Rosen O; Granter SR; Du J; Fletcher JA; Denny CT; Lessnick SL; Linehan WM; Kung AL; Fisher DE
    Cancer Cell; 2006 Jun; 9(6):473-84. PubMed ID: 16766266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.
    Feige E; Yokoyama S; Levy C; Khaled M; Igras V; Lin RJ; Lee S; Widlund HR; Granter SR; Kung AL; Fisher DE
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E924-33. PubMed ID: 21949374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.
    Hsiao JJ; Fisher DE
    Arch Biochem Biophys; 2014 Dec; 563():28-34. PubMed ID: 25111671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
    Haq R; Yokoyama S; Hawryluk EB; Jönsson GB; Frederick DT; McHenry K; Porter D; Tran TN; Love KT; Langer R; Anderson DG; Garraway LA; Duncan LM; Morton DL; Hoon DS; Wargo JA; Song JS; Fisher DE
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4321-6. PubMed ID: 23447565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
    Vachtenheim J; Novotná H
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
    McGill GG; Horstmann M; Widlund HR; Du J; Motyckova G; Nishimura EK; Lin YL; Ramaswamy S; Avery W; Ding HF; Jordan SA; Jackson IJ; Korsmeyer SJ; Golub TR; Fisher DE
    Cell; 2002 Jun; 109(6):707-18. PubMed ID: 12086670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
    Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
    Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.
    Li KK; Goodall J; Goding CR; Liao SK; Wang CH; Lin YC; Hiraga H; Nojima T; Nagashima K; Schaefer KL; Lee KA
    Br J Cancer; 2003 Sep; 89(6):1072-8. PubMed ID: 12966428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
    Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
    Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C
    Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
    Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
    PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].
    Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M
    Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingolipid-mediated restoration of Mitf expression and repigmentation in vivo in a mouse model of hair graying.
    Saha B; Singh SK; Mallick S; Bera R; Datta PK; Mandal M; Roy S; Bhadra R
    Pigment Cell Melanoma Res; 2009 Apr; 22(2):205-18. PubMed ID: 19207217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression.
    Oh TI; Lee YM; Lim BO; Lim JH
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880216
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel stilbene-like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation.
    Stueven NA; Schlaeger NM; Monte AP; Hwang SL; Huang CC
    Toxicol Appl Pharmacol; 2017 Dec; 337():30-38. PubMed ID: 29042215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.